Skip to content

Effects of Proprioceptive Stimulation Under Visual Feedback in Patient With CRPS

Effects of Proprioceptive Stimulation Under Visual Feedback in Patient With CRPS: An Exploratory Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02395211
Enrollment
20
Registered
2015-03-23
Start date
2015-01-31
Completion date
2018-06-30
Last updated
2017-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complex Regional Pain Syndromes

Brief summary

The aim of this study is to evaluate feasibility of a proprioceptive stimulation under visual feedback treatment protocol (using Gloreha® device) compared to usual physiotherapy treatment in sub-acute stroke patient with Complex regional pain syndrome.

Detailed description

The aim of this study is to evaluate feasibility of a a proprioceptive stimulation under visual feedback treatment protocol (using Gloreha® device) compared to usual physiotherapy treatment in sub-acute stroke patient with Complex regional pain syndrome. Treatments effect will be evaluated on pain perception, upper extremity functionality and change in pain pressure treshold. Usual physiotherapy consist of active or passive mobilization, extensor digiti and carpi functional electric stimulation, occupational therapy and taping.

Interventions

Usual physiotherapy consist of active or passive mobilization, extensor digiti and carpi functional electric stimulation, occupational therapy and taping. The intervention will last 30 minute a day x 4 weeks

Proprioceptive stimulation under visual feedback are provided by the Gloreha device. The intervention will last 30 minute a day x 4 weeks

Sponsors

University Hospital of Ferrara
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* age \> 18 years and \< 85 years * diagnosis of stroke \< 6 months prior to study enrollment * diagnosis of Complex regional pain syndrome according to Budapest Criteria

Exclusion criteria

* neurological or psychiatric pathology * severe cardio-pulmonary, renal, hepatic diseases * pregnancy

Design outcomes

Primary

MeasureTime frame
Visual Analogue ScaleChange measures (weeks: 0,4,16, 28)

Secondary

MeasureTime frameDescription
Neuropathic Pain Symptom InventoryChange measures (weeks: 0,4,16, 28)
McGill Pain QuestionnaireChange measures (weeks: 0,4,16, 28)The MPQ is a self-report measure of pain studied with a number of diagnoses. The MPQ assesses both the quality and intensity of subjective pain. The MPQ is composed of 78 words, of which respondents choose those that best describe their experience of pain.
Erasmus MC modification to the (revised) Nottingham Sensory Assessment - Italian versionChange measures (weeks: 0,4,16, 28)
Fugl-Meyer Upper ExtremityChange measures (weeks: 0,4,16, 28)Measure of upper extremity motor impairment. The upper extremity score ranges from 0-66
Pressure Pain ThresholdChange measures (weeks: 0,4,16, 28)

Countries

Italy

Contacts

Primary ContactSofia Straudi, MD
sofia.straudi@gmail.com+ 390532238830
Backup ContactMarco Da Roit, PT
m.daroit@ospfe.it+39 0532238720

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026